Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Macrophages have an important role in the maintenance of tissue homeostasis. To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition. Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth. However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, tumor cells produce lactate which induces the M2 phenotype of TAMs via stabilizing HIF‐1α and activating G‐protein‐coupled receptor 132 [210, 233, 234].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [233]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lactate is known to promote tumor growth [142], angiogenesis [143], and polarize macrophages to express a pro-tumor M2 phenotype [144].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [144]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies have demonstrated that lactate can improve the stability of the HIF-1α protein [9–11].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“These findings indicate that lactate derived from the tumor microenvironment might facilitate HIF-1α-regulated angiogenesis in a hypoxia-independent manner [9].”
From Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Cited by
Items 801–900 of 1,014
Lactate’s impact on immune cells in sepsis: unraveling the complex interplay
Zhang, T., Chen, L., Kueth, G., Shao, E., Wang, X., Ha, T., Williams, D. L., Li, C., Fan, M., & Yang, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483400 · Cited by 100
“Indeed, it is found that lactic acid promotes the transcription of genes associated with M2 macrophage polarization, a process reliant on MCT function, HIF-1 a activation, and induction of inducible cyclic adenosine monophosphate (cAMP) early repressor (ICER) (195 – 198).”
BackgroundMacrophages recycle phagocytosed bacteria to fuel immunometabolic responses
Lesbats, J., Brillac, A., Reisz, J. A., Mukherjee, P., Lhuissier, C., Fernández-Monreal, M., Dupuy, J.-W., Sequeira, A., Tioli, G., De La Calle Arregui, C., et al. (2025) · Nature · doi:10.1038/s41586-025-08629-4 · Cited by 74
Abebayehu, D., Spence, A. J., Qayum, A. A., Taruselli, M. T., McLeod, J. J. A., Caslin, H. L., Chumanevich, A. P., Kolawole, E. M., Paranjape, A. R., Baker, B., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600651 · Cited by 79
“concentrations often exceed 10 mM (19, 27).”
BackgroundResultInfluentialPozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 80
Qayoom, H., Sofi, S., & Mir, M. A. (2023) · Immunologic Research · doi:10.1007/s12026-023-09376-2 · Cited by 77
Ashcraft, K. A., Boss, M., Tovmasyan, A. G., Choudhury, K. R., Fontanella, A. N., Young, K. H., Palmer, G. M., Birer, S. R., Landon, C. D., Park, W., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.07.2283 · Cited by 78
Zhao, Y., Wang, D., Xu, T., Liu, P., Cao, Y., Wang, Y., Yang, X., Xu, X., Wang, X., & Niu, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5538 · Cited by 75
“Subsequently, HIF-1α may create “pseudo-hypoxia” by enhancing the transcription of a series of hypoxia-related genes such as Arg-1, which can metabolize arginine to provide the substrates for cancer cell proliferation [24].”
BackgroundHan, M. S., Barrett, T., Brehm, M. A., & Davis, R. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.008 · Cited by 74
“, 2009) and lactic acid produced by tumor cells (Colegio et al., 2014), that regulate signaling pathways that control macrophage polarization (Zhou et al.”
Peruzzotti-Jametti, L., & Pluchino, S. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.007 · Cited by 75
The Immune Consequences of Lactate in the Tumor Microenvironment
Harmon, C., O’Farrelly, C., & Robinson, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_7 · Cited by 78
“Lactate induces HIF-1a signaling and drives arginase-1 and VEGF expression (Colegio et al., 2014) and synergizes with hypoxia to drive activation of MAPK signaling and arginase-1 expression in tumorassociated macrophages (Carmona-Fontaine et al., 2017).”
BackgroundRabold, K., Aschenbrenner, A. C., Thiele, C., Boahen, C. K., Schiltmans, A., Smit, J. W. A., Schultze, J. L., Netea, M. G., Adema, G. J., & Netea-Maier, R. T. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000638 · Cited by 75
Murphy, D. A., Cheng, H., Yang, T., Yan, X., & Adjei, I. M. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00085 · Cited by 77
Cao, Y., Qiao, B., Chen, Q., Xie, Z., Dou, X., Xu, L., Ran, H., Zhang, L., & Wang, Z. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.02.006 · Cited by 78
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Zhou, Y., Yuan, J. T., Xu, K., Li, S., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c11260 · Cited by 79
The Tumor Microenvironment in Colorectal Cancer Therapy
Pedrosa, L., Esposito, F., Thomson, T. M., & Maurel, J. (2019) · Cancers · doi:10.3390/cancers11081172 · Cited by 69
“, mediated by MMP7) [93], TAMS [88,94], and a lactate-rich TME [95]) would support angiogenesis (VEGFA upregulation) in Cluster 1.”
BackgroundIL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis
Suen, J., Chang, Y., Shiu, Y., Hsu, C., Sharma, P., Chiu, C., Chen, Y., Hour, T., & Tsai, E. (2019) · The Journal of Pathology · doi:10.1002/path.5339 · Cited by 77
“The local IL-10 from tumour cells or macrophages maintains immune suppression [13], and VEGF produced by macrophages [47] promotes angiogenesis in the microenvironment.”
BackgroundT Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
Tang, L., Zhang, Y., Hu, Y., & Mei, H. (2021) · BioMed Research International · doi:10.1155/2021/6616391 · Cited by 80
Radiotherapy-induced metabolic hallmarks in the tumor microenvironment
Mittal, A., Nenwani, M., Sarangi, I., Achreja, A., Lawrence, T. S., & Nagrath, D. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.05.005 · Cited by 84
The gasdermin protein family: emerging roles in gastrointestinal health and disease
Privitera, G., Rana, N., Armuzzi, A., & Pizarro, T. T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00743-w · Cited by 76
Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth
Yan, H., Wang, Z., Teng, D., Chen, X., Zhu, Z., Chen, H., Wang, W., Wei, Z., Wu, Z., Chai, Q., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.10.002 · Cited by 76
Serpina3k lactylation protects from cardiac ischemia reperfusion injury
Wang, L., Li, D., Yao, F., Feng, S., Tong, C., Rao, R., Zhong, M., Wang, X., Feng, W., Hu, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55589-w · Cited by 91
“However, this classic view has been challenged due to emerging roles of lactate as a circulatingcarbohydrate energy source 50 and a signaling molecule 53,54 .”
Qin, T., Wang, C., Chen, X., Duan, C., Zhang, X., Zhang, J., Chai, H., Tang, T., Chen, H., Yue, J., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.021 · Cited by 76
Wang, L., Li, Y., Wang, X., Wang, P., Essandoh, K., Cui, S.-N., Huang, W. C., Mu, X., Liu, Z., Wang, Y., et al. (2020) · Cells · doi:10.3390/cells9010120 · Cited by 77
“Nonetheless, Colegio et al reported that lactate could promote macrophage M2 polarization and inhibit sepsis-induced inflammation [40].”
BackgroundMetabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer
Rogers, T., & DeBerardinis, R. J. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.007 · Cited by 75
A PGE2-MEF2A axis enables context-dependent control of inflammatory gene expression
Cilenti, F., Barbiera, G., Caronni, N., Iodice, D., Montaldo, E., Barresi, S., Lusito, E., Cuzzola, V., Vittoria, F. M., Mezzanzanica, L., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.016 · Cited by 77
Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
Wang, Y., Wang, D., Yang, L., & Zhang, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002426 · Cited by 79
Zhao, J., Tian, Z., Zhao, S., Feng, D., Guo, Z., Wen, L., Zhu, Y., Xu, F., Zhu, J., Ma, S., et al. (2022) · Advanced Science · doi:10.1002/advs.202204808 · Cited by 83
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Luo, Z., Eichinger, K. M., Zhang, A., & Li, S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216396 · Cited by 73
Shang, S., Yang, C., Chen, F., Xiang, R.-S., Zhang, H., Dai, S.-Y., Liu, J., Lv, X.-X., Zhang, C., Liu, X.-T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43548-w · Cited by 74
“Indeed, factors, exosomes or metabolites secreted by cancer stem cells (CSCs) are known to recruit and induce polarization of TAMs 7 – 9 .”
Wang, Z., Wang, Q., Cao, H., Wang, Z., Wang, D., Liu, J., Gao, T., Ren, C., & Liu, J. (2024) · Advanced Materials · doi:10.1002/adma.202311043 · Cited by 78
Naing, A., Papadopoulos, K. P., Pishvaian, M. J., Rahma, O. E., Hanna, G. J., Garralda, E., Saavedra, O., Gogov, S., Kallender, H., Cheng, L., et al. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000249 · Cited by 98
Advances in the interaction of glycolytic reprogramming with lactylation
Li, Y., Cao, Q., Hu, Y., He, B., Cao, T., Tang, Y., Zhou, X. P., Lan, X. P., & Liu, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116982 · Cited by 85
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
“Excess lactate not only serves as an energy source for tumor-associated fi broblasts but also promotes regulatory T cell (Treg) expansion and myeloid-derived suppressor cell polarization, deepening local immune suppression 123,131 .”
Chekulayev, V. A., Mado, K., Shevchuk, I. N., Koit, A., Kaldma, A., Klepinin, A., Timohhina, N., Tepp, K., Kandashvili, M., Ounpuu, L., et al. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.08.020 · Cited by 82
Lactate induces osteoblast differentiation by stabilization of HIF1α
Wu, Y., Wang, M., Feng, H., Peng, Y., Sun, J., Qu, X., & Li, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.017 · Cited by 76
“For the LA treatments, medium without LA was used as a control as indicated previously (Colegio et al., 2014).”
MethodTargeting tumor-associated acidity in cancer immunotherapy
Lacroix, R., Rozeman, E. A., Kreutz, M. P., Renner, K., & Blank, C. U. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2195-z · Cited by 77
Yin, W., Li, Y., Song, Y. Y., Zhang, J., Wu, C., Chen, Y., Miao, Y., Lin, C., Lin, Y., Yan, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024171118 · Cited by 75
Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
Cheng, C., Tan, H., Wang, N., Chen, L., Meng, Z., Chen, Z., & Feng, Y. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.467 · Cited by 78
Yan, C., Yang, Z., Chen, P., Yeh, Y., Sun, C., Xie, T., Huang, W., & Zhang, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03025-8 · Cited by 78
“[19] previously reported that tumor-derived lactate could induce func-tional-polarization of TAMs, likely M2-subtype.”
BackgroundYang, X., Huang, C., Zhong, M., Zhong, H., Ruan, R., Xiong, J., Yao, Y., Zhou, J., & Deng, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02033-1 · Cited by 75
“The production of significant lactate by tumor cells is due to glycolysis, which serves as an intermediary between tumor cells and TAMs, thereby enhancing M2-like polarization through hypoxia-inducible factor 1α (HIF1α) [64].”
Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth
Lakhter, A. J., Hamilton, J., Konger, R. L., Brustovetsky, N., Broxmeyer, H. E., & Naidu, S. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712166 · Cited by 74
“The reliance on aerobic glycolysis of melanoma cells increases lactate secretion, which reprograms the tumor microenvironment to evade the immune system and promote tumor growth (46).”
Porta, C., Sica, A., & Riboldi, E. (2018) · The FEBS Journal · doi:10.1111/febs.14288 · Cited by 69
Yang, Y., Chen, M., Zhou, J., Lv, J., Song, S., Fu, L., Chen, J., Yang, M., & Mei, C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018010074 · Cited by 74
Caslin, H. L., Taruselli, M. T., Haque, T. T., Pondicherry, N., Baldwin, E. A., Barnstein, B. O., & Ryan, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03026 · Cited by 73
Neitzel, C., Demuth, P., Wittmann, S., & Fahrer, J. (2020) · Cancers · doi:10.3390/cancers12071731 · Cited by 76
Lipid-loaded macrophages as new therapeutic target in cancer
Marelli, G., Morina, N., Portale, F., Pandini, M., Iovino, M., Di Conza, G., Ho, P.-C., & Di Mitri, D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004584 · Cited by 69
Determining the effector response to cell death
Rothlin, C. V., Hille, T. D., & Ghosh, S. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00456-0 · Cited by 72
Solute carrier transporters: emerging central players in tumour immunotherapy
Chen, R., & Chen, L. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.002 · Cited by 72
The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
Fridman, E., Ginini, L., & Gil, Z. (2022) · Cells · doi:10.3390/cells11091433 · Cited by 71
Xia, F., Zhao, P., Gao, S., Liu, D., Zhang, S., Shan, M., Wang, Y., Herrmann, J., Li, Q., & Wang, F. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123810 · Cited by 77
Kesarwani, P., Kant, S., Zhao, Y., Prabhu, A. H., Buelow, K. L., Miller, C. R., & Chinnaiyan, P. (2023) · Nature Communications · doi:10.1038/s41467-023-37170-z · Cited by 79
“As the primary cell able to generate QA from tumor-produced Kyn are macrophages, we evaluated for the expression of enzymes involved in the downstream metabolism of tryptophan in mouse derived macrophages using RT- -amyloid (1-42) 0.26 % 12.8% 38.8% 18.7% Isotype M1 M1+QA M2 M2+QA 92.2% c Murine derived microglia Isot…”
MethodInfluentialMonocytes in Tumorigenesis and Tumor Immunotherapy
Chen, X., Li, Y., Xia, H., & Chen, Y. H. (2023) · Cells · doi:10.3390/cells12131673 · Cited by 77
“Tumor hypoxia induces stabilization of the transcription factor hypoxia-inducible factor 1-alpha (HIF-1A), which drives transcriptional responses in both immune cells and cancer cells, thus influencing tumor development [113].”
BackgroundInfluentialLv, Y., Li, M., Weng, L., Huang, H., Mao, Y., Yang, D. A., Wei, Q., Zhao, M., Qin, W. D., Rui, K., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02888-7 · Cited by 80
“ARG1 could inhibit T cell activation and proliferation, leading to T cells dysfunction and allowing tumor cells to escape [43, 44].”
BackgroundPiwócka, O., Piotrowski, I., Suchorska, W. M., & Kulcenty, K. I. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1343523 · Cited by 81
Desgeorges, T., Galle, E., Zhang, J., von Meyenn, F., & Bock, K. D. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101923 · Cited by 76
“The exact contribution of different cell types is however dif fi cult to unravel given existing lactate shuttles and extensive previous work showing that inhibition of lactate production in cells might affect their function and/or metabolism via alternative mechanisms [31,39 e 41].”
BackgroundInfluentialMetabolic reprogramming and interventions in angiogenesis
Liu, Y., Wu, Z., Li, Y., Chen, Y., Zhao, X., Wu, M., & Xia, Y. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.001 · Cited by 74
“Meanwhile, TAMs not only produce VEGF to promote EC proliferation, but also express arginase 1 to reduce local arginine levels and impair T cell functions [155–158].”
Targeting metabolism to enhance immunotherapy within tumor microenvironment
Liang, X., Chen, X., Yan, Y., Cheng, A.-Y., Lin, J.-Y., Jiang, Y.-X., Chen, H., Jin, J., & Luan, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01304-w · Cited by 76
“4) [5].”
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 75
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 77
Niu, X., Ma, J., Li, J., Gu, Y., Yin, L., Wang, Y., Zhou, X., Wang, J., Ji, H., & Zhang, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03781-x · Cited by 70
Heterogeneous Myeloid Cells in Tumors
Dou, A., & Fang, J. (2021) · Cancers · doi:10.3390/cancers13153772 · Cited by 78
“Lactic acid, the end product of glycolysis, is produced by tumor cells and is shown to drive M2 polarization of TAMs via activation of the hypoxia inducible factor 1 subunit alpha (HIF-1α) signaling [17].”
BackgroundLiang, X., Luo, M., Shao, B., Yang, J., Tong, A., Wang, R., Liu, Y., Jun, R., Liu, T., Yi, T., et al. (2022) · Cancer Communications · doi:10.1002/cac2.12272 · Cited by 68
Eisenstein, A. S., Hilliard, B. K., Pope, S. D., Zhang, C., Taskar, P., Waizman, D. A., Israni-Winger, K., Tian, H., Luan, H. H., & Wang, A. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.015 · Cited by 73
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Li, Q., Liu, X., Yan, C., Zhao, B., Zhao, Y., Yang, L., Shi, M., Yu, H., Li, X., & Luo, K. (2023) · Small · doi:10.1002/smll.202206211 · Cited by 80
The neuroimmune connectome in health and disease
Wheeler, M. A., & Quintana, F. J. (2025) · Nature · doi:10.1038/s41586-024-08474-x · Cited by 82
“Indeed, it should also be considered that multiple metabolites important for CNS physiology, such as lactate 109,110 , are potent immunomodulators 108,111 .”
Moore, C., Movia, D., Smith, R. J., Hanlon, D., Lebre, F., Lavelle, E. C., Byrne, H. J., Coleman, J. N., Volkov, Y., & McIntyre, J. (2017) · 2D Materials · doi:10.1088/2053-1583/aa673f · Cited by 72
Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma
Nishida, N., & Kudo, M. (2017) · Oncology · doi:10.1159/000481246 · Cited by 77
Audrito, V., Managò, A., Gaudino, F., Sorci, L., Messana, V. G., Raffaelli, N., & Deaglio, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01720 · Cited by 64
Anstee, J. E., Feehan, K. T., Opzoomer, J. W., Dean, I., Muller, H. P., Bahri, M., Cheung, T. S., Liakath‐Ali, K., Liu, Z., Choy, D., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2023.06.006 · Cited by 70
“8 Heterogeneity within the tumor-associated macrophage (TAM) population arises from the site of TAM origin 9 and the influence of environmental cues within the tumor microenvironment (TME), 3,10,11 which can be guided by both spatial 12,13 and temporal 11 parameters.”
Succinate-loaded tumor cell–derived microparticles reprogram tumor-associated macrophage metabolism
Lu, S., Li, J., Li, Y., Liu, S., Liu, Y., Liang, Y., Zheng, X., Chen, Y., Deng, J., Zhang, H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr4458 · Cited by 77
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
Soncini, M., Corna, G., Moresco, M. A., Coltella, N., Restuccia, U., Maggioni, D., Raccosta, L., Lin, C., Invernizzi, F., Crocchiolo, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613332113 · Cited by 71
“metabolic outliers teach us? Cell 148(6):1132–1144.”
BackgroundInfluentialZhang, W., Chen, L., Ma, K., Zhao, Y., Liu, X., Wang, Y., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12207 · Cited by 73
“BMDMs grown in macrophage colony-stimulating factor (M-CSF) were generated as previously described [35].”
MethodAnnan, D. A., Maishi, N., Soga, T., Dawood, R., Li, C., Kikuchi, H., Hojo, T., Morimoto, M., Kitamura, T., Alam, M. T., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0478-4 · Cited by 74
Tumor associated macrophages and ‘NO’
Nath, N., & Kashfi, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113899 · Cited by 68
Tsai, T., Yang, C., Kou, T., Yang, C., Dai, J., Chen, C., & Lin, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30189 · Cited by 67
Xu, D., Wang, Y., Wu, J., Zhang, Z., Chen, J., Xie, M., Tang, R., Chen, C., Chen, L., Lin, S., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03450-z · Cited by 66
Ning, W.-R., Jiang, D., Liu, X.-C., Huang, Y.-F., Peng, Z.-P., Jiang, Z.-Z., Kang, T., Zhuang, S.-M., Wu, Y., & Zheng, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153110 · Cited by 71
“By comparing metastasis-related genes expressed in paired nontumor tissue– and tumor tissue–purified monocytes, we found that levels of MMP9, VEGFA, and CCL8 were all increased in the tumor monocytes compared with the nontumor monocytes, with CCL8 exhibiting the most marked upregulation (Figure 5A).”
BackgroundIGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
Belfiore, A., Rapicavoli, R. V., Moli, R. L., Lappano, R., Morrione, A., Francesco, E. M. D., & Vella, V. (2023) · Biomedicines · doi:10.3390/biomedicines11010229 · Cited by 76
“However, a subset of TAMs can acquire an M2-like phenotype in response to lactic acid activating HIF1a and independently of IL-4Ra signaling [99].”
BackgroundHong, S. M., Lee, A., Kim, B., Lee, J., Seon, S., Ha, Y., Ng, J. T., Yoon, G., Lim, S. B., Morgan, M. J., et al. (2024) · Advanced Science · doi:10.1002/advs.202303177 · Cited by 84
Zhu, C., Yan, K., Chen, L., Huang, R., Bian, Z.-H., Wei, H.-R., Gu, X., Zhao, Y.-Y., Liu, M.-C., Suo, C., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.007 · Cited by 74
Huang, A., Sun, Z., Hong, H., Yang, Y., Chen, J., Gao, Z., & Gu, J. F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05391-5 · Cited by 81
“Furthermore, considerable lactate accumulation stimulates macrophage polarization to the M2 phenotype in tumors [30].”
BackgroundNorton, K., Jin, K., & Popel, A. S. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.05.003 · Cited by 71
Peñarando, J., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Translational research · doi:10.1016/j.trsl.2019.03.003 · Cited by 69
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Yu, Y.-R., & Ho, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13293 · Cited by 69
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
Cummings, M., Freer, C., & Orsi, N. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.007 · Cited by 71
Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage
Zhang, Q., Wang, J., Yadav, D. K., Bai, X., & Liang, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702580 · Cited by 63
“Simultaneously, lactic acid released by glycolytic cancer cells into the TME also upregulates HIF-1a expression in TAMs responsible for increased glycolysis and M2like state (71, 72).”
Backgroundp53 Promotes Ferroptosis in Macrophages Treated with Fe3O4 Nanoparticles
Wu, C., zhang, B., Shen, Z., Sun, F., Lu, Y., Yuan, L., zhang, G., wang, Z., & Shi, H. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c00707 · Cited by 66
The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment
Luu, M., Schütz, B., Lauth, M., & Visekruna, A. (2023) · Cancers · doi:10.3390/cancers15051588 · Cited by 70
Yang, L., Wang, D., Jia, H., Yang, C., Zhang, Y., Li, H., Liu, J., & Liu, J. (2023) · Advanced Materials · doi:10.1002/adma.202301455 · Cited by 71
Macrophages—bone marrow mesenchymal stem cells crosstalk in bone healing
Fan, S., Sun, X., Su, C., Xue, Y., Song, X., & Deng, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1193765 · Cited by 69
“Recent studies have found that some noncytokine extrinsic pathways such as hypoxia and lactate production can also promote macrophage polarization by regulating macrophage function and metabolism (Colegio et al., 2014; Liu et al., 2020; Noe et al., 2021).”
BackgroundImmunometabolism of tumor-associated macrophages: A therapeutic perspective
Karimova, A. F., Khalitova, A. R., Suezov, R. V., Markov, N., Mukhamedshina, Y. O., Rizvanov, A. A., Huber, M., Simon, H., & Brichkina, A. I. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115332 · Cited by 72
Johns, R. A., Takimoto, E., Meuchel, L. W., Elsaigh, E., Zhang, A., Heller, N. M., Semenza, G. L., & Yamaji-Kegan, K. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306710 · Cited by 68
Alvey, C., & Discher, D. E. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri1216-516r · Cited by 64
Hammami, A., Charpentier, T., Smans, M., & Stäger, S. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004938 · Cited by 64
Metabolic–Epigenetic Crosstalk in Macrophage Activation
Baardman, J., Licht, I., de Winther, M. P., & Van den Bossche, J. (2015) · Epigenomics · doi:10.2217/epi.15.71 · Cited by 62
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors
Faes, S., Duval, A. P., Planche, A., Uldry, É., Santoro, T., Pythoud, C., Stehle, J., Horlbeck, J., Letovanec, I., Riggi, N., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0562-y · Cited by 66
“Consistent with this hypothesis, acidity promotes a tumor promoting phenotype of macrophages [37].”
BackgroundMaca polysaccharides: A review of compositions, isolation, therapeutics and prospects
Li, Y., Xu, F., Zheng, M., Xi, X., Cui, X., & Han, C. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.059 · Cited by 66
Lab on the eye: A review of tear-based wearable devices for medical use and health management
Yu, L., Yang, Z., & An, M. (2019) · BioScience Trends · doi:10.5582/bst.2019.01178 · Cited by 69
Zheng, Y., Han, Y., Wang, T., Liu, H., Sun, Q., Hu, S., Chen, J., & Li, Z. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202108971 · Cited by 78
Choi, H., Yeo, M., Kang, Y., Kim, H. J., Park, S. G., Jang, E., Park, S. H., Kim, E., & Kang, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01762-6 · Cited by 68
“Indeed, tumor-derived lactate in the TME can impair the functions of anti-tumor immune cells, including CD8+ T and NK cells, supporting the generation of immunosuppressive tumor-associated macrophages (TAMs) [19, 48, 49].”
Background
Metadata
- Authors
- Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R.
- Affiliations
- Yale Cancer Center (US)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- ORCID
- Venue
- Nature
- Published
- 2014-07-13
- Volume
- 513
- Issue
- 7519
- Pages
- 559-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4301845
- OpenAlex
- W2063632665
- Cited by
- 3,046
- References
- 24
- Citations by year
- 2026: 359 · 2025: 338 · 2024: 311 · 2023: 338 · 2022: 345 · 2021: 314 · 2020: 269 · 2019: 213 · 2018: 159 · 2017: 161 · 2016: 113 · 2015: 87 · 2014: 23
- FWCI
- 58.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000142)
- National Cancer Institute (R01CA157461, K08CA172580, P50CA121974, CA157461)
- National Institute of Allergy and Infectious Diseases (AI089771, R01AI089771, R37AI046688, AI046688, R01AI046688)
- National Center for Research Resources (KL2RR024138)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- tumour-associated macrophages, lactic acid, M2 macrophage polarization, hypoxia-inducible factor-1α, vascular endothelial growth factor, arginase-1, tumor growth, tumor microenvironment, glycolysis, tissue homeostasis
- MeSH terms
- Animals, Arginase, Cell Communication, Cell Division, Female, Glycolysis, Homeostasis, Macrophages, Male, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, RNA, Messenger, Solubility, Up-Regulation, Culture Media, Conditioned, Carcinoma, Lewis Lung, Lactic Acid, Vascular Endothelial Growth Factor A, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.